Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120393) titled 'Evaluation of the Analgesic-Sedative and Neuroprotective Effects and Safety of Esketamine Combined with Propofol in Patients with Severe Traumatic Brain Injury' on March 13.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The Affiliated Hospital of Southwest Medical University
Condition:
Traumatic brain injury
Intervention:
Control Group:Remifentanil + Propofol for Analgesia and Sedation
Recruitment Status: Recruiting
Phase: 4
Date of First Enrollment: 2025-06-01
Target Sample Size: Control Group:53;Test group:53;
Countries of Recruitment:
China
To know more, visit https...